Accès gratuit
Editorial
Numéro |
Med Sci (Paris)
Volume 28, Numéro 10, Octobre 2012
|
|
---|---|---|
Page(s) | 801 - 803 | |
Section | Éditoriaux | |
DOI | https://doi.org/10.1051/medsci/20122810002 | |
Publié en ligne | 12 octobre 2012 |
- Maehle AH, Prüll CR, Halliwell RF. The emergence of the drug receptor theory. Nat Rev Drug Discov 2002 ; 1 : 637–641. [CrossRef] [PubMed] [Google Scholar]
- Hill SJ. G-protein-coupled receptors: past, present and future. Br J Pharmacol 2006 ; 147 : S27–S37. [CrossRef] [PubMed] [Google Scholar]
- Lewontin R. La triple hélice. Paris : Seuil, 2003 : 154 p. [Google Scholar]
- Chidiac P, Hébert T, Dennis M, Bouvier M. Inverse agonist activity of β2-adrenergic antagonists. Mol Pharmacol 1994 ; 45 : 490–499. [PubMed] [Google Scholar]
- Bond RA, Bouvier M. Inverse agonists and G protein-coupled receptors. In : Leff P, ed. Receptor-based drug design, chap. 16. New York : Marcel Dekker Inc., 1998 : 363–377. [Google Scholar]
- Azzi M, Charest P, Angers S, et al. β-arrestin-dependent activation of MAPK pathway by β2-adrenergic receptor inverse agonists. Proc Natl Acad Sci USA 2003 ; 100 : 11406–11411. [CrossRef] [Google Scholar]
- Kenakin TP. Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 2007 ; 28 : 407–415. [CrossRef] [PubMed] [Google Scholar]
- Galandrin S, Oligny-Longpré G, Bouvier M. The evasive nature of drug efficacy : implications for drug discovery. Trends Pharmacol Sci 2007 ; 28 : 423–430. [CrossRef] [PubMed] [Google Scholar]
- Angers S, Salahpour A, Bouvier M. Dimerization: an emerging concept for G protein-coupled receptors, ontogeny and function. Annu Rev Pharmacol Toxicol 2002 ; 42 : 409–435. [CrossRef] [PubMed] [Google Scholar]
- Smith NJ, Milligan G. Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol Rev 2010 ; 62 : 701–725. [CrossRef] [PubMed] [Google Scholar]
- Palczewski K, Kumasaka T, Hori T, et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000 ; 289 : 739–745. [CrossRef] [PubMed] [Google Scholar]
- Cherezov V, Rosenbaum DM, Hanson MA, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007 ; 318 : 1258–1265. [CrossRef] [PubMed] [Google Scholar]
- Rasmussen SG, Choi HJ, Rosenbaum DM, et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007 ; 450 : 383–387. [CrossRef] [PubMed] [Google Scholar]
- Rosenbaum DM, Cherezov V, Hanson MA, et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007 ; 318 : 1266–1273. [CrossRef] [PubMed] [Google Scholar]
- Onaran H.A, Costa T. Where have all the active receptor states gone? Nat Chem Biol 2012 ; 8 : 674–647. [CrossRef] [PubMed] [Google Scholar]
- Rasmussen SG, Choi HJ, Fung JJ, et al. Structure of a nanobody-stabilized active state of the beta2 adrenoceptor. Nature 2011 ; 469 : 175–180. [CrossRef] [PubMed] [Google Scholar]
- Rasmussen SG, DeVree BT, Zou Y, et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 2011 ; 477 : 549–555. [CrossRef] [PubMed] [Google Scholar]
- Wu B, Chien EY, Mol CD, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010 ; 330 : 1066–1071. [CrossRef] [PubMed] [Google Scholar]
- Manglik A, Kruse AC, Kobilka TS. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 2012 ; 485 : 321–326. [CrossRef] [PubMed] [Google Scholar]
- Wu H, Wacker D, Mileni M, et al. Structure of the human kappa-opioid receptor in complex with JDTic. Nature 2012 ; 485 : 327–332. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.